Welcome to Medications.com

Toprol-XL Information

What's inside Toprol-XL

Toprol-XL Active Ingredients: metoprolol succinate, details.
Toprol-XL Dosages & Strengths
Strength Format Route Strength Class
Toprol-XL 50 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 200 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 25 mg tablet, extended release oral 1.0 each OTC
Toprol-XL 100 mg tablet, extended release oral 1.0 each OTC

Recent Toprol-XL Side Effects

Posted by laurieannwinter 18 days ago
I was on 50 mg. then increased to 100 mg. After about 10-14 days on the 100's, I began itching all over ... broke out in a h...

Posted by tombis 29 days ago
Hello everyone. I am a 40 year old female and have been on Toprol XL 50 mg. for about 6 years now. In the beginning I was tak...

Posted by dreamer52 about 1 month ago
I've been having PVC's for about four months with tachycardia. My doctor put me on the generic for Toprol -- 50 mg. For two d...


Toprol-XL in the News

ROUNDUP AstraZeneca's strengthened pipeline fails to impress as ... - Euro2day
... chief financial officer Simon Lowth predicted that revenues from MedImmune would cancel out losses incurred from generic competition to Toprol-XL in 2008.
Thu Jan 31 10:57:01 -0500 2008

Intestinal bleeding requires some care immediately - San Bernardino Sun
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 21:01:46 -0500 2008

Intestinal bleeding requires some care immediately - San Gabriel Valley Tribune
I was then placed on Toprol XL. After several weeks, I started to get dizzy and lightheaded. I was told to monitor my pressure, which I do. ...
Sat Feb 02 20:56:50 -0500 2008


Toprol-XL Chemical Information

metoprolol succinate - The succinate salt form of metoprolol, a cardioselective competitive beta-1 adrenergic receptor antagonist with antihypertensive properties and devoid of intrinsic sympathomimetic activity. Metoprolol succinate antagonizes beta 1-adrenergic receptors in the myocardium, thereby reducing the rate and force of myocardial contraction, and consequently a diminished cardiac output. This agent may also reduce the secretion of renin with subsequent reduction in levels of angiotensin II thus decreasing sympathetic activation, including vasoconstriction, aldosterone secretion.




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea